OFFICIAL PUBLICATION OF

pdl.com.au

by its subsidiary APPco

New Hepatitis C treatment TGA registered

Megan Haggan 06/09/2016

Hepatitis Virus - 3D Render

The TGA has registered a new treatment regimen for the treatment of chronic Hepatitis C.MSD announced that Zepatier (elbasvir/grazoprevir) with or without ribavirin has been registered by the TGA for the treatment of chronic hepatitis C virus genotype 1 and 4 infection in adults.The regimen is a once-daily tablet taken for 12 weeks, and is

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Did wave of protest fail to break?

Or busy waging war against the ALP...

Morbidly Obese John

Did wave of protest fail to break?

The Pharmacy Guild has submitted a response on behalf of members to the ACCC’s review of the proposed merger of…

Anthony Tassone

Hi, I’m your pharmacist!

Best thing I heard in my pre-reg year (some 40 years ago!)- a wonderful locum I worked under said to…

Brendan West

Transaction fees drive MedAdvisor growth

Transaction fees??? Are they business partners??? And from the regulators we hear…. Crickets

Paul Sapardanis